CNTB
Connect Biopharma
CNTB
CNTB
16 hedge funds and large institutions have $10.9M invested in Connect Biopharma in 2023 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 6 reducing their positions, and 5 closing their positions.
Holders
16
Holders Change
-4
Holders Change %
-20%
% of All Funds
0.26%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
2
Reduced
6
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
UOC
1
UBS O'Connor
Chicago,
Illinois
|
$574K |
2 |
![]()
2
JPMorgan Chase & Co
New York
|
$79K |
3 |
3
Renaissance Technologies
New York
|
$89K |
Top Sellers
1 |
SCM
1
Sio Capital Management
New York
|
$0 |
2 |
2
Citigroup
New York
|
$0 |
3 |
E
3
Ergoteles
New York
|
$0 |
4 |
TRCT
4
Tower Research Capital (TRC)
New York
|
$0 |
5 |
5
UBS Group
Zurich,
Switzerland
|
$9.34K |